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Abstract
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biomass‐derived sugars. This inhibition can interfere with economically viable production. Here we discuss
typical mechanisms of inhibition and methods for improving biocatalyst robustness. Inhibition often takes the
form of inhibition of enzyme activity, depletion of cofactor pools, and membrane damage; methods are
discussed for mitigating each of these types of inhibition. Various evolutionary schemes have been developed
and implemented on a variety of inhibitory compounds, including butanol, acetic acid, furfural, and ethanol.
Reverse engineering of these improved strains can provide insight into new metabolic engineering strategies.
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Metabolic Engineering for Biocatalyst Robustness to
Organic Inhibitors
Liam Royce and Laura R. Jarboe
4134 Biorenewables Research Laboratory, Department of Chemical and Biological Engineering,
Iowa State University, Ames, IA, USA
7.1 Introduction
The ﬁeld of metabolic engineering has grown enormously since its deﬁni-
tion in 1991 (Bailey 1991; Stephanopoulos and Vallino 1991). Since then,
enormous progress has been made in the use of engineered microbes for
production of biorenewable fuels and chemicals. Two years after its initial
deﬁnition, Cameron and Tong classiﬁed ﬁve types of metabolic engineering:
enhanced production of native metabolites; heterologous production of
foreign metabolites; utilization of new substrates for metabolism; improved
or new metabolic pathways for chemical degradation; and modiﬁcation of cell
properties that facilitate bioprocessing (Cameron and Tong 1993). Many land-
mark metabolic engineering projects have dealt with the ﬁrst three strategies,
including but not limited to (Ohta et al. 1991; Zhang et al. 1995; Steinbuchel
2001; Nakamura and Whited 2003; Jeﬀries and Jin 2004; Lutke-Eversloh and
Stephanopoulos 2007; Atsumi et al. 2008), and can be thought of as relating
mainly to metabolic functionality. Here we focus on the modiﬁcation of cell
properties that facilitate bioprocessing. Such modiﬁcations have focused on
a wide variety of biocatalyst properties; here we focus on the property of
biocatalyst robustness, particularly in regards to organic inhibitor tolerance.
This improved robustness can be geared toward increasing product tolerance,
possibly enabling increased product titers, and increased ability to use “dirty”
biomass-derived sugars.
While industrial (Chotani et al. 2000) and academic researchers (Zeng
and Biebl 2002; Demain 2006; Jarboe et al. 2007; Yan and Liao 2009) have
reported attainment of high titers, yields, and productivities for some prod-
ucts, this is something that remains diﬃcult to achieve, especially with
next-generation biofuels and biochemicals. High product titers are desirable
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to make downstream separation steps cost-eﬀective, but can be toxic to
the microbial biocatalyst. Biocatalyst inhibition is also problematic when
biomass-derived sugars are used as the fermentation substrate, as biomass
hydrolysate or pyrolysate (“dirty sugars”) contains trace contaminants that
are inhibitory to the microbe (Mills et al. 2009; Lian et al. 2010; Jarboe et al.
2011a). This toxicity means that the amount of sugars that can be utilized by
the organism is limited, and thus the amount of product formed is decreased
relative to fermentations using “clean” sugars. One approach for dealing with
this product or feedstock toxicity is to remove the inhibitory compounds
(Martinez et al. 2000; Lennen et al. 2010; Lian et al. 2010; Lakshmanaswamy
et al. 2011; Chi et al. 2013). However, here we focus on the complementary
approach of improving microbial robustness to organic inhibitors. Note that
there are also reports of inhibitory side products; these can often be addressed
by re-distribution of the metabolic ﬂux (Agrawal et al. 2012).
Biocatalyst robustness as it relates to the economically viable production of
fuels and chemicals has been discussed in a variety of recent reviews (War-
necke and Gill 2005; Fischer et al. 2008; Mills et al. 2009; Nicolaou et al. 2010;
Dunlop 2011; Jarboe et al. 2011b). In this chapter, we highlight some of the
key concepts in this ﬁeld and cover some of the recent ﬁndings.The discussion
includes metabolic evolution coupled with reverse engineering, a valuable tool
for gaining insight into the mechanism of inhibition and strategies for increas-
ing tolerance. Figure 7.1 highlights the possible mechanisms of inhibition by
organic compounds, while Table 7.1 lists successful strategies to increase toler-
ance. Most of our discussion involves either Escherichia coli or Saccharomyces
cerevisiae, since they are the two most commonly used organisms both for
metabolic engineering and for understanding tolerance.
Biorenewable fuels and chemicals
Biomass
Metabolic
currency (i.e. ATP)
Biocatalytic machinery
(i.e. enzymes)
Carbon, nutrients, energy
2
3
1
Figure 7.1 Reported mechanisms of inhibition often take the form of (1) inhibition
reactions that produce metabolic precursors, limiting the formation of biomass and/or the
enzymes needed for metabolism; (2) depletion of general metabolic precursors, such as ATP
and NADPH; (3) damage to the cell membrane, interfering with membrane-associated
reactions, and retention of valuable metabolites.
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Table 7.1 Common types of microbial inhibition by organic inhibitors.
General mechanism Example Source
Inhibition of
production of
essential metabolites
Depletion of NADPH by
aldehyde reduction limits
production of cysteine
Miller et al. (2009a)
Inhibition of methionine
biosynthesis during acetate
challenge
Whitﬁeld et al. (1970),
Roe et al. (2002)
Inhibition of isoleucine and
leucine biosynthesis during
valine challenge
Manten and Rowley (1953)
Inhibition of chorismate and
threonine production by 3-HP
Warnecke et al. (2010)
Membrane damage Membrane leakage induced
during carboxylic acid
challenge and production
Zaldivar and Ingram (1999),
Lennen and Pﬂeger (2013), Liu
et al. (2013), Royce et al. (2013)
Reduced function of
membrane-associated
processes during carboxylic
acid challenge
Teixeira et al. (2004), Cipak et al.
(2008), Ruenwai et al. (2011)
Intracellular
acidiﬁcation
Low intracellular pH during
acetate challenge
Trcek et al. (2015)
7.2 Mechanisms of Inhibition
The mechanism by which diﬀerent compounds limit biocatalyst growth and
metabolism vary according to the chemistry of the molecule. Discussed in this
section are inhibition of production of essential metabolites, such as amino
acids and nucleotides, membrane damage, and perturbation of intracellular
pH (Table 7.1), but it should be noted that there are a variety of known
pathogenesis-related inhibition mechanisms, such as antibiotics and reactive
oxygen or reactive nitrogen species (Wright 2003; Dzidic et al. 2008; De
Pascale and Wright 2010). Omics analysis, such as transcriptome analysis, has
often played a key role in identiﬁcation of these mechanisms of inhibition, as
reviewed elsewhere (Jarboe et al. 2011b).
Given the necessity of amino acids and nucleotides for production of
proteins, transcripts, and genome replication, disturbance of their produc-
tion can lead to biocatalyst inhibition. This can be especially problematic
when the desired growth condition is deﬁned minimal media, relative to
metabolite-containing rich media. Depletion of essential metabolic building
blocks can trigger the global stringent response (Jain et al. 2006; Durfee et al.
2008). For example, it was shown that the biomass-derived inhibitor furfural
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indirectly inhibits cysteine production in E. coli by depleting the NADPH
needed for conversion of sulfate to hydrogen sulﬁde (Miller et al. 2009a). The
accumulation of carboxylate ions in E. coli, such as during challenge with car-
boxylic acids, can increase the intracellular ionic strength to levels suﬃcient to
inhibit homocysteine transmethylase (MetE), an enzyme required for methio-
nine biosynthesis (Whitﬁeld et al. 1970; Roe et al. 2002). The feedback loop
that regulates valine production in E. coli results in valine-mediated inhibition
of production of leucine and isoleucine. Thus, valine can be inhibitory to
some E. coli strains when leucine and isoleucine are not exogenously supplied
(Manten and Rowley 1953). 3-Hydroxypropionic acid (3-HP) can limit amino
acid synthesis via inhibition of the chorismate and threonine superpathway
(Warnecke et al. 2010). This limitation of biosynthesis pathways is distinct
from situations where the product compound inhibits its own production;
enzyme improvement for alleviating this problem has been reviewed elsewhere
(Jarboe et al. 2012).
Another commonly noted mechanism of inhibition is membrane damage.
This is especially problematic when dealing with hydrophobic compounds,
such as carboxylic acids and butanol (Lennen et al. 2011; Jarboe et al. 2013;
Liu et al. 2013; Royce et al. 2013). Overton’s Rule provides a general rule of
thumb for predicting the membrane permeability of a compound, whereby
compounds with increased lipid solubility (i.e. hydrophobicity) have greater
membrane permeability (Al-Awqati 1999). Membrane damage can mani-
fest as a failure to maintain appropriate ﬂuidity and/or leakage of valuable
metabolites. Leakage is often monitored using Mg2+ as a reporter molecule
(Zaldivar and Ingram 1999; Liu et al. 2013; Royce et al. 2013) or permeability
to nucleic acid stains (Lennen and Pﬂeger 2013). Fluidity can be measured via
the diﬀusivity of a ﬂuorescent reporter molecule (Beney et al. 2004; Mykytczuk
et al. 2007). Recent studies have visualized membrane pores, and eventual
disintegration, caused by an antimicrobial peptide (Rakowska et al. 2013),
though such studies have not yet been performed with the type of inhibitors
of interest here. Membrane damage can result in improper functioning of
membrane-associated reactions, such as the electron transport chain, some-
times resulting in increased production of reactive oxygen species (Teixeira
et al. 2004; Cipak et al. 2008; Ruenwai et al. 2011).
Exogenous challenge with carboxylic acids, especially acetate, has been
shown to disrupt intracellular pH (Viegas et al. 1998; Ricke 2003; Royce et al.
2014; Trcek et al. 2015). This drop in intracellular pH is due to dissociation
of the carboxylic acid in the cell interior. The acidiﬁcation can inhibit cellular
processes and impose a hefty ATP burden as ATPase is used to remove the
excess protons (Viegas et al. 1998).
Thus, biocatalyst inhibition can occur at a variety of levels and scales. Inhi-
bition of a single biosynthesis-related enzyme can completely inhibit biosyn-
thesis of the machinery needed for growth and metabolism. An increase in the
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harshness of the intracellular environment, such as increased osmotic stress
or a drop in pH can stress multiple enzymes. Depletion of generic cofactors,
such as NAD(P)H and ATP, can have a general slowing eﬀect on metabolism.
Membrane damage can impact membrane-associated processes and result in
leakage of valuable metabolites. A variety of metabolic engineering strategies
have been demonstrated for dealing with these various types of inhibition.
7.3 Mechanisms of Tolerance
Strategies for increasing biocatalyst robustness of organic inhibitors have arisen
both as a deliberate response to known mechanisms of inhibition and from
analysis of evolved strains. Here we highlight a few of these knownmechanisms
(Table 7.2), while evolutionary strategies to increase tolerance are described
later in this chapter.
A design scheme that has arisen somewhat independently of known inhibi-
tion mechanisms or analysis of evolved strains is the provision of appropriate
transporter proteins. This strategy asserts that product toxicity can be alle-
viated, at least in part, by providing cells with the opportunity to expel the
problematic compound. This strategy has proven eﬀective in improving both
tolerance and production of limonene (Dunlop et al. 2011) and valine (Park
et al. 2007) by E. coli, as well as alkane tolerance in S. cerevisiae (Ling et al.
2013), geraniol tolerance in E. coli (Shah et al. 2013) and decanoate tolerance
in E. coli (Lennen et al. 2013).
Problems with biosynthesis due to inhibition of enzyme activity can be
addressed by replacing the sensitive enzyme with an isozyme or mutant
enzyme that is resistant to the inhibitory eﬀect. This approach has been
successfully demonstrated with both valine and 3-HP (Warnecke et al. 2010;
Park et al. 2011). Depletion of generic cofactors, such as furfural-mediated
depletion of NADPH, can be addressed by either deleting the enzyme respon-
sible for this depletion (Miller et al. 2009b) or implementingmetabolic changes
to increase cofactor availability (Wang et al. 2011, 2013; Zheng et al. 2013).
For instance, provision of an NADH-dependent furfural reductase enabled E.
coli to reduce furfural to the less toxic furfuryl alcohol, while not depleting the
NADPH needed for biosynthesis (Wang et al. 2011; Zheng et al. 2013).
Acetate and other organic acids are known to decrease the intracellular pH
of microorganisms, as previously discussed.The balance between extracellular
and intracellular pH greatly aﬀects the proton motive force (PMF), which is
important for ATP production and transport processes. E. coli can adapt to
changes in pH by accommodating the electrochemical potential (the balance of
chemical charges) in order tomaintain the appropriate PMF (Royce et al. 2014).
Other adaptations of organic acid tolerance include addition of cyclopropane
fatty acids in the cell membrane, as discussed below.
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Table 7.2 Commonmethods for improving tolerance.
Method Example Source
Provision of
exporters for the
inhibitory
compound
Production of limonene Dunlop et al. (2011)
Production of valine Park et al. (2007)
Alkane tolerance Ling et al. (2013)
Membrane
engineering
Alteration of the distribution of
saturated and unsaturated fatty acids
improved ethanol tolerance
Luo et al. (2009)
Alteration of the distribution of
saturated and unsaturated fatty acids
improved carboxylic acid tolerance
Lennen and Pﬂeger (2013)
Directed evolution Improved isobutanol tolerance Atsumi et al. (2010), Minty et al. (2011)
Improved tolerance of biomass
hydrolysate
Huang et al. (2009), Mills et al. (2009),
Geddes et al. (2011)
Enrichment of
expression
libraries
multi-SCalar Analysis of Library
Enrichments (SCALEs)
Gall et al. (2008), Warnecke et al.
(2010, 2012), Sandoval et al. (2011),
Woodruﬀ et al. (2013)
Global transcription machinery
engineering (gTME)
Alper and Stephanopoulos (2007, Pan
et al. (2009), Zhang et al. (2010), Chen
et al. (2011), Liu et al. (2011), Ma et al.
(2011), Yang et al. (2011), Lanza and
Alper (2012), Ma and Yu (2012), Wang
et al. (2012), Chong et al. (2013)
Combinatorial
expression of
protective genes
Ethanol tolerance Nicolaou et al. (2012)
As mentioned above, membrane damage is a frequently cited mechanism of
inhibition and membrane-associated genes have been identiﬁed in the analysis
of many strains evolved for various tolerance phenotypes (Sandoval et al. 2011;
Woodruﬀ et al. 2013). For this reason, we have designated a distinct section for
describing membrane engineering eﬀorts.
7.4 Membrane Engineering
Modulation of the membrane composition enables microbes to respond to
environmental challenges (Zhang and Rock 2008). The lipid-rich cell mem-
brane is often targeted at the molecular level by hydrophobic compounds.
As described above, this can result in decreased ability of the membrane to
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retain valuable metabolites and decreased function of membrane-associated
metabolic processes. For this reason, many of the most interesting recent
breakthroughs in metabolic engineering for inhibitor tolerance are related to
membrane engineering. We describe these results here, after a brief summary
of the physiological role of the diﬀerent bacterial membrane components.
Bacterialmembranes are amixture ofmany diﬀerent lipid entities (Table 7.3).
Each lipid species plays a distinct physiological role.Themain lipid component
of the E. colimembrane is the straight-chain, unsaturated palmitic acid (C16:0).
Table 7.3 Physiological signiﬁcance of selected types of bacterial membrane lipids.
OH
O
C14:0 not shown: C12:0, C18:0
E. colimembranes contain
minor amounts of these
lipids. E. coli incorporates
C14:0 into lipid A (Raetz
et al. 2007). Fluidity is
dependent on chain length
and degree of saturation;
short lipids increase
ﬂuidity and long lipids
decrease ﬂuidity
OH
OOH
3-hydroxy-C14:0
C12:0 or C14:0 fatty acids
bind to the hydroxyl group
of 3-hydroxy-C14:0 in lipid
A of E. coli
OH
O
C16:0 (palmitic acid)
E. coli bacteria membranes
are predominantly C16:0
OH
O
Cyclopropane C17cyc not shown: C19cyc
Gram-negative bacteria
incorporate more
cyclopropane fatty acids
during stationary phase as
a stress response (Chang
and Cronan 1999). C17cyc
helps mediate acid stress
OH
O
Monounsaturated cis-C16:1 not shown: C18:1
An increase in unsaturated
lipids increases membrane
ﬂuidity
(Continued)
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Table 7.3 (Continued)
OH
O
trans C18:1
Trans fatty acids occur
naturally in Pseudomonas
putida, which is
solvent-tolerant. The trans
species acts like saturated
fatty acids by decreasing
membrane ﬂuidity (Zhang
and Rock 2008)
OH
O
Polyunsaturated C18:3 not shown: C18:2
Generally present in
gram-positive bacteria (e.g.
Lactobacillus plantarum)
OH
O
Branched iso-C17:0
Membrane ﬂuidity
depends on iso or anteiso
forms. These lipids are
usually observed in
gram-positive bacteria.
Combined substituents are
also possible- iso-C17:1
and anteiso-C17:1
OH
O
Branched anteiso-C17:0
OH
O
Docosahexaenoic acid (DHA) 22:6(n−3) not shown: EPA 20:5(n−3)
DHA and other long chain
polyunsaturated fatty acids
are unique to marine
bacteria. PUFA increase
membrane ﬂuidity in cold,
high pressure
environments (Urakawa
et al. 1998)
Typical metrics for describing membrane composition include average chain
length and the unsaturated/saturated ratio. A variety of studies have reported
changes in both of these metrics in response to challenge with inhibitory com-
pounds (Lennen et al. 2011; Wu et al. 2012; Liu et al. 2013; Royce et al. 2013).
Palmitic acid can bymodiﬁed by either changing the length of the carbon back-
bone or adding a substituent such as a double bond or cyclopropane group
(Table 7.2). An important note is that cyclopropane lipids are formed as an
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intramembrane modiﬁcation of a cis-unsaturated fatty acid and not from de
novo fatty acid biosynthesis (Zhang and Rock 2008).
The available modiﬁcations to standard membrane lipids and relative
distribution are dependent on the bacterial species and the environment.
For example, branched lipids are a major component in the membrane of
gram-positive bacteria (Cronan and Thomas 2009). Branched fatty acids can
increase or decrease membrane ﬂuidity, dependent upon the ante- or iso-
conformation (Zhang and Rock 2008). The diﬀerence comes from the packing
eﬃciency of the fatty acid within the lipid bilayer. The methyl group in the
anteiso form is further away from the end, which increases the bulk. Another
intriguing variable is the presence of cyclopropane fatty acids. These occur
when the double bond in unsaturated lipids is methylated, such as by the E. coli
Cfa enzyme (Grogan and Cronan 1997). Teichoic acid is a major component
in the cell wall of gram-positive bacteria and provides structural rigidity to
the cell wall by cross-linking peptidoglycan layers (Moat et al. 2002). Sterols
increase the membrane rigidity, decreasing passive transport of lactic acid
and its resulting accumulation (Vanderrest et al. 1995). Peptidoglycan is a
three-dimensional mesh outside the plasma membrane and can serve as a
structural barrier against osmotic pressure and toxic compounds (Heidrich
et al. 2002; Typas et al. 2012). The outer layer of polymers on the surface
of a bacteria cell, known as lipopolysaccharides (LPS), can also be a protec-
tion against inhibitors. The hydrophobicity and surface charge of the cell is
attributed to LPS and may aﬀect the interaction of the cell with inhibitors
(Aono and Kobayashi 1997; Lee et al. 2009).
Each lipid component has an overall eﬀect on the ﬂuidity of the membrane
through hydrophobic interactions between the lipids and proteins in the mem-
brane (Zhang and Rock 2008). Membrane ﬂuidity is an important part of cellu-
lar physiology and aﬀects the function of the membrane, including respiration,
passive and active transport, and protein function. Typically, as the length of
the fatty acid increases the membrane ﬂuidity decreases due to a higher pack-
ing eﬃciency (Mykytczuk et al. 2007). Fatty acid length has also an eﬀect on
the membrane thickness (Lewis and Engelman 1983; In’t Veld et al. 1991) and
curvature (Xu et al. 2008). The membrane thickness is important for proper
membrane function such as protein conformation and nutrient transport (In’t
Veld et al. 1991; Engelman 2005).Membrane ﬂuidity is temperature-dependent;
at low temperatures, bacterial membranes are generally less ﬂuid (Zhang and
Rock 2008). Moritella marina, a bacterial species found in deep, cold ocean
waters (Kautharapu and Jarboe 2012) copes with this by producing polyunsat-
urated fatty acids that then increase the ﬂuidity of the membrane.
Membrane ﬂuidity needs to be in an optimal range for proper membrane
function. Solvents, such as alcohols and aromatics, have a ﬂuidizing eﬀect on
the membrane (Bernal et al. 2007; Huﬀer et al. 2011), and thus a change in
the membrane ﬂuidity is needed to counterbalance ﬂuidizing agents. Bacteria
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respond to solvent stress in a number of ways, most notably a change in
the membrane lipid composition. The ethanol producer Zymomonas mobilis
contains relatively more octadecenoic fatty acid (C18:1) than E. coli (Liu and
Qureshi 2009). It has been shown that E. coli exposure to ethanol increases
the relative amount of C18:1 compared to C16:0. This change is accompanied
by an altered growth rate and membrane ﬂuidity (Ingram 1982; Liu and
Qureshi 2009). This diﬀerence in membrane composition could explain why
Z. mobilis has increased ethanol tolerance. Bacillus cereus predominantly
uses branched lipids in its membrane; the relative abundance of saturated and
iso-branched lipids increases during anaerobiosis, presumably in response
to ethanol production (de Sarrau et al. 2012). Biosynthesis of teichoic acid
and capsular polysaccarides by Lactobacillus plantarum is stimulated by
the presence of ethanol (van Bokhorst-van de Veen et al. 2011), leading to
the suggestion that an increase in the cell wall thickness can act as a barrier
against solvents.
Cyclopropane fatty acids have been demonstrated as useful (Chang and Cro-
nan 1999; Shabala andRoss 2008), but not essential (To et al. 2011) formicrobial
acid tolerance. Motivated by an observed increase in both saturated and cyclo-
propane fatty acids in Clostridium acetobutylicum during butanol challenge
(Vollherbstschneck et al. 1984), Zhao et al. overexpressed the native cfa gene in
C. acetobutylicum. This increased Cfa expression did enable increased butanol
tolerance, though it was unfortunately accompanied by decreased butanol pro-
duction (Zhao et al. 2003). It may be that a change in the membrane properties
ofC. acetobutylicum upon overexpression of cfa decreased solventogenesis. Liu
et al. enabled cyclopropane fatty acid production in S. cerevisiae, an organ-
ism that does not inherently produce these compounds, in order to mitigate
membrane leakage during octanoic acid challenge (Liu et al. 2013). While the
cyclopropane fatty acids were successfully produced, there was no change in
octanoic acid tolerance.
Luo et al. increased expression of the native fabA desaturase in E. coli with
the goal of improving ethanol tolerance (Luo et al. 2009). This fabA overex-
pression increased the saturated lipid content and improved ethanol tolerance.
The physiological eﬀect of fabA overexpression is not clear at this time, but an
increase in saturated fatty acids inherently decreases the ﬂuidity of the mem-
brane, possibly either aﬀectingmembrane functions or the transport of ethanol
into the cell.
Similarly, Lennen and Pﬂeger noted a decrease in saturated fatty acid content
in the cell membrane during production of carboxylic acids and proposed that
this change in membrane composition was actually a mechanism of carboxylic
acid toxicity. They successfully engineered their strain to restore closer to
normal saturated fatty acid content, though levels were still lower than that
observed for the nonproducing control strain (Lennen and Pﬂeger 2013). The
viability of the modiﬁed carboxylic-acid producing strains was signiﬁcantly
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increased in the strain engineered for increased saturated fatty acid content
(Lennen and Pﬂeger 2013). Other membrane engineering strategies inspired
by microbial evolution experiments are discussed below.
7.5 Evolutionary and Metagenomic Strategies
for Increasing Tolerance
Evolution is essentially a selection of random mutations that confer increased
ﬁtness (Elena and Lenski 2003; Demain 2006; Beaume et al. 2013; Kussell 2013).
These mutations can take a variety of forms and inﬂuence protein function via
changes in amino acid sequence or increased, decreased, or even total lack of
gene expression. This evolutionary process has been leveraged in the develop-
ment of strains with useful metabolic behaviors (Yomano et al. 2008; Zhang
et al. 2009; Cobb et al. 2012; Reyes et al. 2013; Jin et al. 2016), but here we
are more interested in its use in the development of strains with increased
robustness to organic inhibitors. While these robust strains are inherently use-
ful, identifying and understanding the mutations that confer increased robust-
ness can enable development of strain engineering strategies. The idea that we
can distill metabolic engineering strategies from the evolved strains follows
the proverb commonly known as Orgel’s Second Rule: “evolution is cleverer
than you are.” The results of reverse engineering studies are included in a dis-
tinct section below. Table 7.4 lists selected reports of evolutionary studies for
ethanol, acetate, and butanol.
The most basic evolutionary studies take advantage of the natural “back-
ground” mutation rate. For wild-type E. coli, the most recent estimate for the
rate of point mutations is 8.9× 10−11 events per base pair per generation (Wiel-
goss et al. 2011). The mutation rate can be increased by the use of mutagens,
such as ethyl methane sulfonate (EMS) (Kim et al. 2007), or deletion of proof-
reading enzymes, such as the methyl-directed mismatch repair system (Shaver
et al. 2002). Such studies have successfully evolved tolerance to inhibitory
compounds, such as furfural (Lin et al. 2009; Miller et al. 2009b), isobutanol
(Atsumi et al. 2010; Minty et al. 2011), 2-butanol (Ghiaci et al. 2013), acetic
acid (Steiner and Sauer 2003), biomass pyrolysate (Liang et al. 2013), biomass
hydrolysate (Huang et al. 2009;Mills et al. 2009; Geddes et al. 2011), and others.
In this traditional evolutionary scheme, cells are typically subdiluted in batch
cultures on a regular basis (i.e. every 24 or 48 hours) or upon attainment of a
certain cell density. Inhibitor concentration is typically increased in a stepwise
fashion as cells gain tolerance. An interesting variation of this traditional
approach is the Visualizing Evolution in Real Time (VERT) method, in which
ﬂuorescence-based cell sorting is used to track distinct gains in ﬁtness (Reyes
et al. 2012a; Winkler and Kao 2012; Winkler et al. 2013); the utility of this
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Table 7.4 Evolution for inhibitor tolerance. It is important to note that many mutations are
synergistic in development of the ﬁnal tolerance phenotype.
Organism Evolutionary method Result Reference
Inhibitor: Ethanol
E. coli SCALEs Enriched populations in 15 and
30 g l−1 ethanol in minimal media
Woodruﬀ et al. (2013)
Transcription
Machinery
Engineering of Sigma
70
Final strain showed growth (6-h
doubling time) in the presence of
60 g l−1 ethanol in rich media;
control strain had no growth
Alper and
Stephanopoulos (2007)
Transcription
Machinery
Engineering of CRP
Final strain had a growth rate of
0.08 h−1 in the presence of 62 g l−1
ethanol, relative to 0.06 h−1 of
original strain
Chong et al. (2013)
Transcription
Machinery
Engineering of IrrE
Best strain showed a 10-fold
increase in the number of cells
surviving 1-h shock with 12.5%
ethanol
Chen et al. (2011)
S. cerevisiae Transcription
Machinery
Engineering of Spt15
Signiﬁcantly improved viability
during 30 h of culturing with 20%
ethanol
Alper and
Stephanopoulos (2007)
Transcription
Machinery
Engineering of Spt15
Evolved strains grew in the
presence of 15% ethanol; control
strain did not tolerance
concentrations above 10%
Yang et al. (2011)
Inhibitor: Acetate
E. coli SCALEs Enriched population in 1.75 g l−1
acetate in minimal media at
neutral pH
Sandoval et al. (2011)
Transcription
Machinery
Engineering of IrrE
Best strain showed increased
growth in the presence of 0.05%
acetate in rich medium
Chen et al. (2011)
Inhibitor: Butanol
E. coli Sequential transfers Increased growth and viability in
the presence of 6 and 8 g l−1
isobutanol in rich medium
Atsumi et al. (2010)
Sequential transfers Increased growth in the presence
of 1% (w/v) isobutanol
Minty et al. (2011)
VERT At least 10-fold increased survival
to shock with 2 vol% n-butanol
for 1 h in minimal medium
Reyes et al. (2012b)
Transcription
Machinery
Engineering of IrrE
Best strain showed a 100-fold
increase in the number of cells
surviving 1-h shock with 2.1%
butanol
Chen et al. (2011)
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method was demonstrated during evolution of n-butanol tolerance in E. coli
(Reyes et al. 2012b).
Other evolutionary-type studies rely on growth-based selection for improved
tolerance, but do not only rely on the natural background mutation rate. His-
torically, transposon mutagenesis to randomly inactivate genes has been an
eﬀective method for identifying genes involved in a particular phenotype
(Suzuki et al. 2008). The multi-SCalar Analysis of Library Enrichments
(SCALEs) method uses a plasmid library containing E. coli genomic fragments
of various lengths to comprehensively increase expression of individual genes
and gene clusters (Gill et al. 2002; Lynch et al. 2007; Bonomo et al. 2008;
Warner et al. 2009). DNA fragments and genes conferring increased tolerance
to the focal compound are identiﬁed and interpreted. This approach has been
used with ethanol (Woodruﬀ et al. 2013), acetate (Sandoval et al. 2011), 3-HP
(Warnecke et al. 2010, 2012), and 1-naphthol (Gall et al. 2008).
Another opportunity for biological discovery is the use of metagenomic
screens, in which a plasmid library is generated from a mixture of various
genomes and screened for the desired activity in an inhibitory condition, are
most often used to ﬁnd enzymes that are tolerant to speciﬁc stresses (Lu et al.
2013; Shi et al. 2013). However, a search of a DNA library generated from the
human gut microbiota not only identiﬁed multiple salt-tolerant Collinsella
genes, they also found that expression of these genes in E. coli resulted in
increased salt tolerance (Culligan et al. 2012). These metagenomic screens
provide the opportunity to discover and utilize tolerance-conferring genes
from organisms or pathways that have not yet been characterized.
Expression libraries typically only enable expression of one gene or multiple
genes that are co-located within the genome. It has been shown that a stepwise,
combinatorial approach to expression libraries can further improve tolerance
(Nicolaou et al. 2011). This approach has been demonstrated, for example, in
regards to oxidative stress (Nicolaou et al. 2013), acid stress (Gaida et al. 2013),
and ethanol (Nicolaou et al. 2012).
Instead of relying on altered expression of a few plasmid-associated
genes, global transcription machinery engineering (gTME) uses variants of
genetic regulators to perturb the expression of multiple genes (Alper and
Stephanopoulos 2007; Lanza and Alper 2012). For example, ethanol tolerance
in E. coli has been addressed by enriching library of cAMP receptor protein
mutants (Chong et al. 2013), Rhodococcus ruber tolerance of acrylamide
and acrylonirtrile through mutation of sigma 70 (Ma and Yu 2012), ethanol
and biomass hydrolysate tolerance in S. cerevisiae through mutation of the
TATA-binding protein (Liu et al. 2011; Yang et al. 2011). gTME can also be
applied to a foreign regulator. Speciﬁcally, a mutation library of IrrE global reg-
ulator from radiation-resistant Deinococcus radiodurans has been introduced
into E. coli and screened for resistance to a variety of inhibitors, such as ethanol,
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butanol, acetate, osmotic stress, biomass hydrolysate, and salt stress (Pan et al.
2009; Zhang et al. 2010; Chen et al. 2011; Ma et al. 2011; Wang et al. 2012).
7.6 Reverse Engineering of Improved Strains
One of the major beneﬁts of reverse engineering-evolved strains is the
opportunity for biological discovery. For example, reverse engineering of
furfural-tolerant E. coli identiﬁed YqhD as the major E. coli furfural reductase
(Miller et al. 2009b). However, not all reverse engineering results are so
clear-cut. Analysis of the results of SCALEs for 3-HP tolerance identiﬁed the
21-amino acid peptide IroK as important to 3-HP tolerance, independent of
3-HP transport, but the biological function of this peptide remains unknown
at this time (Warnecke et al. 2012).
Several analyses of E. coli strains evolved for isobutanol or n-butanol toler-
ance have noted possible changes in LPS content or composition (Atsumi et al.
2010; Minty et al. 2011; Reyes et al. 2013). One evolved isobutanol-tolerant
mutant had an insertion mutation that essentially inactivated the gene yhbJ ,
a mutation that can lead to increased production of glucosamine-6-phosphate,
a major component of peptidoglycan and LPS synthesis (Atsumi et al. 2010).
Another reverse engineering of isobutanol-tolerant E. coli found mutations in
fepE and yjgQ, which contribute to LPS synthesis as well as eptB, which adds a
phophoethanolamine group (a type of phospholipid) to LPS (Minty et al. 2011).
Minty et al. found that amutated form, designated hfq*, can increase isobutanol
tolerance (Minty et al. 2011). Hfq is an RNA-binding protein that aﬀects RNA
processing and regulation.
Each of these diﬀerent evolutionary methods and subsequent reverse engi-
neering eﬀorts provide the opportunity to gain insight intomechanisms of inhi-
bition and methods for increasing tolerance. These methods usually highlight
multiple genes and traits that lead to a combinatorial form of tolerance. Note
that it has been challenging to distill clear design strategies from some of the
more advanced evolutionary schemes due to the large number of genes with
perturbed expression.
It is important to note that many mutations found in evolution studies are
synergistic in development of the ﬁnal tolerance phenotype; rarely does one
mutation dominate. It was suggested that global regulators at the transcrip-
tional and post-transcriptional levelmay be key components inmetabolic engi-
neering for tolerance due to their vast reach over the genome. Interestingly,
stress responses may either overlap (van Bokhorst-van de Veen et al. 2011) or
be antagonistic (Reyes et al. 2013). This result is consistent with the idea that
genes of overlapping function have a negative epistasis (He et al. 2010). Epista-
sis can be quantiﬁed by a multiplicative ﬁtness model (Minty et al. 2011) that
can analyze how particular mutations are aﬀected by subsequent mutations.
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7.7 Concluding Remarks
Production of biorenewable fuels and chemicals from biomass is desirable as
a means of potentially increasing energy security, stabilizing fuels costs and
addressing climate change and increasing carbon dioxide levels. Microbes
are an appealing biocatalyst for this production and excellent strategies and
techniques for rationally and predictably engineering biocatalyst metabolism
have been developed. However, biocatalyst inhibition by either the prod-
uct compound or inhibitors in the cheap, “dirty,” biomass-derived sugars
remain problematic in the attainment of economically viable yields, titers,
and productivities. Multiple approaches can be used to increase titers and
productivities: removal of the inhibitory organic compounds, redistribution of
metabolic ﬂux to limit production of inhibitory side products, and improving
microbial robustness. Here we have summarized representative mechanisms
of inhibition and evolutionary and engineering strategies for increasing toler-
ance. Evolutionary strategies have proven quite adept at increasing tolerance
(Table 7.1), but additional eﬀorts on reverse engineering these improved
strains can provide guidance for new design strategies.
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